Systemic lupus erythematosus, progressive multifocal leukoencephalopathy, and T-CD4+ lymphopenia

Clinical Reviews in Allergy and Immunology

Volumn 43, Issue 3, 2012, Pages 302-307

  Brandão, Mariana ^a   Damásio, Joana ^a   Marinho, António ^a   Da Silva, Ana Martins ^a   Vasconcelos, Júlia ^a   Neves, Esmeralda ^a   Almeida, Isabel ^a   Farinha, Fátima ^a   Vasconcelos, Carlos ^a,b  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Autoimmune diseases; Intravenous immunoglobulin; Progressive multifocal leukoencephalopathy; Systemic lupus erythematosus; T CD4+ lymphopenia

Indexed keywords

ANTICOAGULANT AGENT; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; CD69 ANTIGEN; CD71 ANTIGEN; CIDOFOVIR; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA ANTIBODY; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INTERLEUKIN 2 RECEPTOR ALPHA; METHOTREXATE; RITUXIMAB; SM ANTIBODY; STEROID; THALIDOMIDE;

ADULT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; ATAXIA; BRAIN BIOPSY; CASE REPORT; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CHOREA; CYTOMEGALOVIRUS INFECTION; DEEP VEIN THROMBOSIS; DYSGRAPHIA; DYSMETRIA; FEMALE; GAIT DISORDER; HALLUCINATION; HEADACHE; HEMOPHAGOCYTIC SYNDROME; HERPES ZOSTER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LISTERIOSIS; LOW DRUG DOSE; LYMPHOCYTOPENIA; NYSTAGMUS; OBSERVATIONAL STUDY; OPPORTUNISTIC INFECTION; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PSYCHOSIS; RASH; RESTLESSNESS; RETROSPECTIVE STUDY; STEROID THERAPY; SUBSTITUTION THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT RESPONSE; VERTIGO;

ADULT; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; T-LYMPHOCYTOPENIA, IDIOPATHIC CD4-POSITIVE;

EID: 84871661016     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-012-8327-x     Document Type: Article

References (40)

1. Major EO (2010) Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu Rev Med 61:35-47
2. Palazzo E, Yahia SA (2012) Progressive multifocal leukoencephalopathy in autoimmune diseases. Joint Bone Spine. doi:10.1016/j.jbspin.2011.11.002
3. Molloy ES, Calabrese LH (2009) Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum 60:3761-3765
4. Amend KL, Turnbull B, Foskett N, Napalkov P, Kurth T, Seeger J (2010) Incidence of progressive multifocal leukoencephalopathy in patients without HIV. Neurology 75:1326-1332
5. Calabrese LH, Molloy ES, Huang DR, Ransohoff RM (2007) Progressive multifocal leukoencephalopathy in rheumatic diseases. Arthritis Rheum 56:2116-2128
6. Molloy ES, Calabrese LH (2008) Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk? Autoimmun Rev 8:144-146
7. Molloy ES (2011) PML and rheumatology: the contribution of disease and drugs. Cleve Clin J Med 78(Suppl 2):S28-S32
8. Graff-Radford J, RobinsonMT,Warsame RM, Matteson EL, Eggers SD, Keegan BM(2012) Progressive multifocal leukoencephalopathy in a patient treated with etanercept. Neurologist 18:85-87
9. Gonçalves FG, Lamb L, Del Carpio-O'Donovan R (2011) Progressive multifocal leukoencephalopathy restricted to the posterior fossa in a patient with systemic lupus erythematosus. Braz J Infect Dis 15:609-612
10. Pavlovic AM, Bonaci-Nikolic B, Kozic D et al (2012) Progressive multifocal leukoencephalopathy associated with mycophenolate mofetil treatment in a woman with lupus and CD4+ Tlymphocyte deficiency. Lupus 21:100-102
11. Molloy ES, Calabrese LH (2012) Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies. Arthritis Rheum. doi:10.1002/art.34468
12. Boren EJ, Cheema GS, Naguwa SM, Ansari AA, Gershwin ME (2008) The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases. J Autoimmun 30:90-98
13. White MK, Khalili K (2011) Pathogenesis of progressive multifocal leukoencephalopathy -revisited. J Infect Dis 203:578-586
14. Monaco MC, Atwood WJ, Gravell M, Tornatore CS, Major EO (1996) JC virus infection of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: implications for viral latency. J Virol 70:7004-7012 (Pubitemid 26307415)
15. Koralnik IJ (2006) Progressive multifocal leukoencephalopathy revisited: has the disease outgrown its name? Ann Neurol 60:162-173 (Pubitemid 44182391)
16. Houff SA,Major EO, Katz DA et al (1988) Involvement of JC virusinfected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. N Engl J Med 318:301-305 (Pubitemid 18034522)
17. Tan CS, Dezube BJ, Bhargava P et al (2009) Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIVnegative patients: implications for viral latency and neurotropic transformation. J Infect Dis 199:881-888
18. Du Pasquier RA, Autissier P, Zheng Y, Jean-Jacques J, Koralnik IJ (2005) Presence of JC virus-specific CTL in the cerebrospinal fluid of PML patients: rationale for immune-based therapeutic strategies. AIDS 19:2069-2076 (Pubitemid 41668994)
19. Koralnik IJ, Du Pasquier RA, Kuroda MJ et al (2002) Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope. J Immunol 168:499-504 (Pubitemid 34014154)
20. Shah R, Bag AK, Chapman PR, Curé JK (2010) Imaging manifestations of progressive multifocal leukoencephalopathy. Clin Radiol 65:431-439
21. Pelosini M, Focosi D, Rita F et al (2008) Progressive multifocal leukoencephalopathy: report of three cases in HIV-negative hematological patients and review of literature. Ann Hematol 87:405-412
22. Carson KR, Evens AAM, Richey EA et al (2009) Progressive multifocal leukoencephalopathy after rituximab therapy in HIVnegative patients: a report of 57 cases from the research on adverse drug events and reports project. Blood 113:4834-4840
23. Epker JL, van Biezen P, van Daele PL, van Gelder T, Vossen A, van Saase JL (2009) Progressive multifocal leukoencephalopathy, a review and an extended report of five patients with different immune compromised states. Eur J Intern Med 20:261-267
24. Ferreira S, Vasconcelos J, Marinho A et al (2009) Linfopenia T CD4 no lupus eritematoso sistémico. Acta Reumatol Port 34:200-206
25. Ng WL, Chu CM, Wu AK, Cheng VC, Yuen KY (2006) Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus. QJM 99:37-47 (Pubitemid 43124970)
26. Narula S, LaRosa DF, Kamoun M, Dalmau J, Levinson AI (2007) Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency and abnormal CD8+ T-cell subset distribution. Ann Allergy Asthma Immunol 98:483-489 (Pubitemid 46752643)
27. Angelini L, PietrograndeMC,Delle PianeMR et al (2001) Progressive multifocal leukoencephalopathy in a child with hyperimmunoglobulinE recurrent infection syndrome and review of literature. Neuropediatrics 32:250-255 (Pubitemid 33134250)
28. Coutinho A, Carneiro-Sampaio M (2008) Primary immunodeficiencies unravel critical aspects of the pathophysiology of autoimmunity and of the genetics of autoimmune disease. J Clin Immunol 28(Suppl 1):S4-S10
29. Haider S, Nafziger D, Gutirriez JA, Brar I, Mateo N, Fogle J (2000) Progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia: a case report and review of reported cases. Clin Infect Dis 31:e20-e22
30. Smith DK, Neal JJ, Holmberg DS (1993) Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. N Engl J Med 328:373-379
31. Patel A, Patel J, Ikwuagwu J (2010) Treatment of progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia. J Antimicrob Chemother 65:2489-2492
32. Wladis EJ, Kapila R, Chu DS (2005) Idiophatic CD4+ lymphocytopenia and Sjogren syndrome. Arch Ophtalmol 123:1012 (Pubitemid 41058006)
33. Berger JR (2010) Progressive multifocal leukoencephalopathy and newer biological agents. Drug Saf 33:969-983
34. Clifford DB, Ances B, Costello C et al (2011) Rituximabassociated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Arch Neurol 68:1156-1164
35. Terrier B, Hummel A, Fakhouri F et al (2007) Progressive multifocal leukoencephalopathy in a non-AIDS patient: high efficiency of combined cytarabine and cidofovir. Rev Med Interne 28:488-491 (Pubitemid 46970870)
36. Geschwind MD, Skolasky RI, Royal WS, McArthur JC (2001) The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS. J Neurovirol 7:353-357 (Pubitemid 32894241)
37. Royal W 3, Dupont B, McGuire D (2003) Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy. J Neurovirol 9:411-419 (Pubitemid 36874717)
38. O'Reilly S (1997) Efficacy of camptothecin in progressive multifocal leukoencephalopathy. Lancet 350:291 (Pubitemid 27312311)
39. Marzocchetti A, Tompkins T, Clifford DB et al (2009) Determinants of survival in progressive multifocal leukoencephalopathy. Neurology 73:1551-1558
40. Elphick GF, Querbes W, Jordan JA et al (2004) The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306:1380-1383 (Pubitemid 39532516)